Read key information about the Brazilian Biosciences Industry
Track the success of BRAZIL PAVILION at BIO2009 International Convention, Atlanta/Georgia, USA.
The Brazilian Pavilion at BIO2009 International Convention was a huge success. The event, considered the most important biobusiness meeting in the world, was held on May 18 to 21st in Atlanta, USA with more than 14.000 participants from 48 different countries. The pavilion was organized by Fundação Biominas and APEX Brasil.
20 Brazilian life sciences companies, presented at the pavilion, had the opportunity to show their products and services and discuss business opportunities. Also, an important public official delegation attended the event, including governmental and fostering institutions’ relevant members related to science and technology. In total, Brazil had more than 100 people at BIO 2009.
The pavilion and delegation confirms the Brazilian commitment to develop the life sciences industry, in compliance with the Productive Development Policy in Biotechnology launched by the Brazilian Federal Government for the biennium from 2009 to 2010.
The Brazil Pavilion had its number of exhibitors doubled in comparison with the previous year. Fundação Biominas has already booked a place even bigger for 2010 and estimates the participation of 30 companies and an increasing attendance of the Brazilian delegation.
Fundação Biominas is a company dedicated to create and develop life science companies in Brazil since 1990. We also establish relationships with public and private institutions, to promote and develop the sector, offering specialized services to companies – in their various stages of development –, investors and academics, providing differentiated infrastructure, forming partnerships with government agencies in life science projects, and support international companies wishing to establish business and partnerships in Brazil.
During Bio 2009, we promoted the Brazil Session, with the theme "Recent Developments and Partnering Opportunities in Agricultural Biotechnology in Brazil", in which the Secretary for Policy and R&D Programs of the Ministry of Science and Technology, Dr. Luiz Antonio Barreto de Castro (mediator) and a well-known researcher of EMBRAPA, Dr. Dario Grattapaglia (speaker) described the progress achieved by Brazil in the agricultural biotechnology area, promoting the institutions involved in the development of this area in the country and featuring partnerships with institutions and companies from over the world.
Another Pavilhão Brasil’s novelty this year was the distribution of a promotional material (CD) featuring the Life Science Companies in Brazil and containing a Directory of Life Science Companies. This material is also available for download.
+ Life Science Industry in Brazil 2009
+ Directory of Brazilian Life Science – Data Base of Companies
Check out the photos Pavilion Brazil, BIO 2009. Click here!
We invite you all to know the Fundação Biominas. If there is a need, do not hesitate to contact us by phone +55 31 3303-0001 or by e-mail biominas@biominas.org.br.
________________________________________________________________________________
Emerging Biotechnology Clusters
Genetic Engineering and Biotechnology News, the most read publication in the field of biotechnology around the world, recently identified some of the key and most promising clusters of the sector. Among them, the city of Belo Horizonte was considered as one of the three leading biotechnology clusters in Brazil, with focus on Biominas Foundation, specialized in generating business opportunities and integration with governments and venture capitalists.
Read the paper in full
Brazil featured at Nature Biotechnology
Paper presents an in-depth look into Brazil’s Health Biotech
It was recently published at Nature Biotechnology a study on Brazil’s Health Biotech Sector and the challenges and opportunities it currently faces. The paper “Brazilian health biotech—fostering crosstalk between public and private sectors” was authored by researchers at the McLaughlin-Rotman Centre for Global Health (University of Toronto), Wharton Health Care Systems (University of Philadelphia) and Burrill & Company. According to the study, Brazil boasts world-class biomedical science, but tension between the public and private sectors hinders progress in health biotech innovation.
The article is freely available at the following link
Brazilian health biotech - Additional problems and few solutions
The Feature article provides a commendable analysis of the Brazilian health biotech industry and its growing pains. Read all the effort that the Ministry of Science and Technology in Brazil has been made over the past three years.
Read the paper in full
